Iron is essential for energy production, oxygen transport and countless biochemical reactions, yet excess free iron triggers destructive chemistry that damages DNA, proteins and membranes. Researchers at MIT—Ankur Jain, Whitney Henry and Pushkal Sharma—found that cells use small molecules called polyamines as iron storage lockers, keeping the metal in a non‑reactive form and preventing iron overload toxicity. Polyamine concentrations in cells are comparable to ATP, far exceeding their known role of binding RNA. A genome‑wide screen revealed that lowering polyamine levels makes the protein GPX4 essential for survival; GPX4 protects membrane lipids from peroxidation. At the same time, an iron‑binding protein rises, indicating iron is stored in a mineralized state. To test the hypothesis, the team created a fluorescent sensor that lights up in the presence of chemically reactive iron and combined it with an existing polyamine sensor. Live‑cell imaging showed that as polyamine levels drop, reactive iron increases, directly linking polyamines to iron detoxification. This mechanism has therapeutic implications: cancer cells rely on high polyamine levels for rapid growth, and combining polyamine‑depleting drugs with GPX4 inhibitors could kill cancer cells more effectively than targeting either pathway alone. Moreover, mutations in polyamine transport genes are associated with early‑onset Parkinson’s disease, which also shows elevated brain iron; polyamine‑mediated iron buffering offers a plausible connection. The new iron sensor is expected to aid studies of aging, cancer and neurodegeneration by enabling real‑time tracking of reactive iron in living cells.
Review